On the latest ABA Pandemic Update, Paul Benda does not have much good news to report. He discusses the Delta surge, vaccine effectiveness and safety, new CDC mask guidance, an unwelcome delay on the COVID vaccine for those 12 and under, and he tries to figure out how bad things will get before they get better.

In this episode of the ABA Pandemic Update, ABA SVP Paul Benda discusses the Delta variant and some ways parents can think about the risk it poses to their kids who can't be vaccinated, examines a poll about common misconceptions regarding the effectiveness of different mitigating actions like hand-washing, looks at the FDA announcement about their review of the Pfizer vaccine for full licensure and talks travel trends and what it means for the future.

ABA SVP Paul Benda returns with a Pandemic Update after a brief hiatus, and unfortunately things have changed substantially in the last two weeks. Today it's all about the delta variant. Benda talks about how and why cases are trending upward, shares some good news on recovered immunity, examines what schools may look like in the fall, and touches on the need for booster doses.

ABA SVP Paul Benda discusses getting a booster shot if you've had Johnson and Johnson vaccine, delta variant-driven increases in cases in the central part of the country, how delta has affected the U.K. and Israel, a Kaiser Family Foundation survey about businesses and vaccines, the real risk from vaccine-induced myocarditis and a new paper that provides hope that most of the population may not need any booster shots.

ABA SVP Paul Benda covers the Delta variant of COVID-19 and its impact on younger populations, reviews vaccine effectiveness, looks at computer models and where they think we'll be this fall, reviews a new study on how well vaccines work on those with cancer and examines how birthday parties may have contributed to the spread of COVID.

ABA's Paul Benda discusses about some new vaccine data from Novavax, the effect the Delta variant is having on the UK and how it's spreading in the U.S., the FDA meeting regarding vaccinations for kids, whether vaccines causing heart inflammation and some updates on the legality of vaccine mandates and OSHA's emergency temporary standard.

ABA SVP Paul Benda talks about the race to get 70% of the population vaccinated, reviews recovered immunity and what it might mean for the summer and fall, discusses some concerning data around the COVID-19 delta variant that originated in India, and look at the CDC study around hospitalized adolescents that concerned CDC Director Rochelle Walensky.

ABA SVP Paul Benda discusses the WHO naming convention of new COVID-19 variants, the impact one of those variants is having on the United Kingdom and what it means for the U.S., metrics that may determine when we get booster shots, new summer camp guidance from the CDC, EEOC update on rules surrounding workers and vaccinations and a brief update on regulators' back-to-work plans.

ABA SVP Paul Benda reviews vaccination progress and case counts, takes a detailed look at vaccine effectiveness against the primary strain circulating in India, gives an update on Moderna's plans, reviews a new article on durability of recovered immunity, shares some good news and bad news for pregnant women, revisits the theory on COVID escaping from a Wuhan lab, and examines how the pandemic may evolve and end.

ABA SVP Paul Benda covers the updated CDC guidance on masks and what it means for banks and discusses the latest vaccination and infection rates. He also provides a brief but worrying comparison of infection rates of the current pandemic with the 1918 pandemic, reviews some vaccine effectiveness data, talks about booster shots and reviews some of the history around the aerosolization debate.